Roche

ROCHE NEWSROOM (896 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

ABB registered more patent applications with the European Patent Office than any other Swiss-based company in 2014

PRESS RELEASE -- 27, February 2015

In 2014, ABB filed more patent applications in Europe than any other company in Switzerland, for the second consecutive year Zurich, Switzerland, 27-02-2015 — /EuropaWire/ — ABB, the leading power and automation technology group, registered more patent applications with the … Read the full press release →

Roche received second Breakthrough Therapy Designation from FDA for its investigational cancer immunotherapy MPDL3280A (anti-PDL1)

PRESS RELEASE -- 3, February 2015

Second FDA Breakthrough Therapy Designation for MPDL3280A following bladder cancer in 2014 BASEL, 3-2-2015 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received a second Breakthrough Therapy Designation from the United States Food and … Read the full press release →

Roche commences cash tender offer for up to 15,604,288 outstanding shares of common stock of Foundation Medicine, Inc. at a price of $50.00 per share

PRESS RELEASE -- 3, February 2015

BASEL, 3-2-2015 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for up to 15,604,288 outstanding shares of common stock of Foundation Medicine, Inc. (NASDAQ: FMI) at a price of … Read the full press release →

Roche to acquire up to 56.3% interest in Foundation Medicine, Inc. on a fully diluted basis through a tender and acquisition of newly issued shares

PRESS RELEASE -- 12, January 2015

BASEL, 12-1-2015 — /EuropaWire/ — Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer Roche to acquire a majority interest in Foundation Medicine (FMI) of up to 56.3% on a fully diluted basis … Read the full press release →

Roche acquired molecular diagnostics testing service provider Ariosa Diagnostics, Inc. based in San Jose, Calif.

PRESS RELEASE -- 3, December 2014

BASEL, 3-12-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA. Ariosa is a molecular diagnostics testing service provider that provides a … Read the full press release →